Skip to Menu Skip to Search Contact Us USA Websites & Languages Skip to Content



Apr 16, 2013, 08:30


Apr 17, 2013, 17:00


Boston, United States

The 12th Annual Biosimilars conference will face important questions associated with cost-effective methods of developing biosimilars, key regulatory issues, safety assessments both clinical & non-clinical methods and the future of biosimilars.

Why should delegates attend?

  • Explore the future and opportunities of biosimilars
  • Discuss clinical development strategies of biosimilars
  • Examine commercialization of biosimilars
  •  Learn cost-effective methods of manufacturing high-quality biosimilars
  • Evaluate challenges in developing biosimilars/ follow-on biologics
  • Understand  the key regulatory, scientific issues and latest developments of biosimilars
  • Discover the process development of biosimilars including technical consideration
  • Discuss immunogenicity
  • Gain insight into the role the US, European and Asia markets will have in developing biosimilars
  • Network and discuss ideas with industrial experts and market leaders


Visit us April 16-17 at The Seaport Hotel and discuss your upcoming projects with SGS experts.